Related Experiment Videos
Antioxidants and atherosclerosis progression: unresolved questions
1King Gustaf V Research Institute, Karolinska Institute, Stockholm, Sweden.
Current Opinion in Lipidology
|August 1, 1994
Summary
Antioxidants show antiatherosclerotic effects in animals, and vitamin E may benefit heart health in humans. Further research is needed to confirm antioxidant benefits and mechanisms in human atherosclerosis.
Area of Science:
- Cardiovascular Research
- Nutritional Science
- Oxidative Stress Biology
Background:
- Antioxidants exhibit antiatherosclerotic properties in animal models.
- Epidemiological studies suggest potential benefits of high-dose vitamin E for coronary heart disease.
- The precise roles of LDL oxidation and antioxidants in human atherosclerosis remain under investigation.
Purpose of the Study:
- To review the current understanding of antioxidants and atherosclerosis.
- To discuss the unresolved questions regarding LDL oxidation and antioxidant efficacy in humans.
- To highlight the need for further clinical investigation into antioxidant mechanisms and effects on lesion progression.
Main Methods:
- Review of existing animal studies on antioxidant antiatherosclerotic actions.
- Analysis of prospective epidemiological data on vitamin E and coronary heart disease.
- Discussion of scientific literature concerning LDL oxidation and antioxidant roles in atherosclerosis.
Main Results:
- Animal studies support antioxidant antiatherosclerotic actions.
- Epidemiological data indicate potential benefits of high-dose vitamin E for major coronary heart disease.
- Clinical evidence for antioxidant efficacy in retarding human atherosclerosis progression is currently lacking.
Conclusions:
- While animal studies are promising, human clinical trials are necessary to establish the antiatherosclerotic effects of antioxidants.
- The mechanisms by which antioxidants might influence atherosclerosis in humans require further elucidation.
- Further research is essential to determine if antioxidants can effectively slow lesion progression in human cardiovascular disease.